EUVIMEDEUVIMED entdecken
Crossref

β-Galactosidase-activated near-infrared AIEgen for ovarian cancer imaging in vivo

Lingling Xu, Hang Gao, Yu Deng, Xiaoyang Liu, Wenjun Zhan, Xianbao Sun, Jing-Juan Xu, Gaolin Liang

Biosensors and Bioelectronics · 2024-07 · 255 · 116207

DOI: 10.1016/j.bios.2024.116207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2024-07. Verfasst von Lingling Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, Chi…. Hauptthemen laut MEDLINE: Biosensing Techniques, Ovarian Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Key Technologies Research and Development Program, Jiangsu Province Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Near-infrared (NIR) aggregation induced-emission luminogens (AIEgens) circumvent the noisome aggregation-caused quenching (ACQ) effect in physiological milieu, thus holding high promise for real-time and sensitive imaging of biomarkers in vivo. β-Galactosidase (β-Gal) is a biomarker for primary ovarian carcinoma, but current AIEgens for β-Gal sensing display emissions in the visible region and have not been applied in vivo. We herein propose an NIR AIEgen QM-TPA-Gal and applied it for imaging β-Gal activity in vitro and in ovarian tumor model. After being internalized by ovarian cancer cells (e.g., SKOV3), the hydrophilic nonfluorescent QM-TPA-Gal undergoes hydrolyzation by β-Gal to yield hydrophobic QM-TPA-OH, which subsequently aggregates into nanoparticles to turn NIR fluorescence "on" through the AIE mechanism. In vitro experimental results indicate that QM-TPA-Gal has a sensitive and selective response to β-Gal with a limit of detection (LOD) of 0.21 U/mL. Molecular docking simulation confirms that QM-TPA-Gal has a good binding ability with β-Gal to allow efficient hydrolysis. Furthermore, QM-TPA-Gal is successfully applied for β-Gal imaging in SKOV3 cell and SKOV3-bearing living mouse models. It is anticipated that QM-TPA-Gal could be applied for early diagnosis of ovarian cancers or other β-Gal-associated diseases in near future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosensing TechniquesOvarian NeoplasmsAnimalsHumansMiceFemaleFluorescent DyesMolecular Docking SimulationOptical Imagingbeta-Galactosidase

Stichwörter der Autor:innen

Aggregation-induced emissionFluorescence imagingNear-infraredOvarian cancerβ-Galactosidase

Substanzen

Fluorescent Dyesbeta-Galactosidase

Autor:innen und Institutionen

  • State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, China.
  • State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, China.
  • State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, China; Handan Norman Technology Co., Ltd., Guantao, 057750, China.
  • State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, China; Handan Norman Technology Co., Ltd., Guantao, 057750, China. Electr…

Förderung

  • Key Technologies Research and Development Program
  • Jiangsu Province Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Xu, L., Gao, H., Deng, Y., Liu, X., Zhan, W., Sun, X., Xu, J. J., & Liang, G. (2024). β-Galactosidase-activated near-infrared AIEgen for ovarian cancer imaging in vivo. Biosensors and Bioelectronics, 255, 116207. https://doi.org/10.1016/j.bios.2024.116207

Vancouver

Xu L, Gao H, Deng Y, Liu X, Zhan W, Sun X, et al. β-Galactosidase-activated near-infrared AIEgen for ovarian cancer imaging in vivo. Biosensors and Bioelectronics. 2024;255:116207. doi:10.1016/j.bios.2024.116207

BibTeX
@article{Xu2024,
  author = {Xu, Lingling and Gao, Hang and Deng, Yu and Liu, Xiaoyang and Zhan, Wenjun and Sun, Xianbao and Xu, Jing-Juan and Liang, Gaolin},
  title = {β-Galactosidase-activated near-infrared AIEgen for ovarian cancer imaging in vivo},
  journal = {Biosensors and Bioelectronics},
  year = {2024},
  volume = {255},
  pages = {116207},
  doi = {10.1016/j.bios.2024.116207}
}
Kostenlos starten →